Literature DB >> 17028774

Recombinant expression of human cathelicidin (hCAP18/LL-37) in Pichia pastoris.

In-Pyo Hong1, Sung-Jae Lee, Yong-Seok Kim, Shin-Geon Choi.   

Abstract

The constitutive expression of human cathelicidin LL-37 antimicrobial peptide was achieved using the methylotrophic yeast, Pichia pastoris. An LL-37 cDNA clone was amplified by PCR using human fetal cDNA library as template. The 111 bp fragment encoding mature LL-37 gene was subcloned into pGAPZ-E, an episomal form of the pGAPZB vector incorporating PARS1. It was then transformed into the P. pastoris X-33 strain for intracellular expression. A small peptide with a molecular mass of about 5 kDa was detected by 17% peptide-PAGE analysis. The recombinant LL-37 peptide was purified from the gel and its amino acid sequence was determined by LC-ESI-MS/MS analysis. The initiating amino acid, methionine, was still attached to the N-terminal region of recombinant LL-37. LL-37 crude extract from P. pastoris showed an antimicrobial activity against Micrococcus luteus as the test strain. The successful expression of human LL-37 indicates that the system may be applicable to the expression of other human defensins without resorting to fusion protein constructions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028774     DOI: 10.1007/s10529-006-9202-8

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  7 in total

1.  Peptide-based Antifungal Therapies against Emerging Infections.

Authors:  A Matejuk; Q Leng; M D Begum; M C Woodle; P Scaria; S-T Chou; A J Mixson
Journal:  Drugs Future       Date:  2010-03       Impact factor: 0.148

2.  Heterologous Expression and Functional Characterization of CAP18 from Oryctolagus cuniculus.

Authors:  Mahla Nikpoor; Azadeh Lohrasbi-Nejad; Jafar Zolala
Journal:  Rep Biochem Mol Biol       Date:  2022-01

3.  Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33.

Authors:  Ruoyu Mao; Da Teng; Xiumin Wang; Yong Zhang; Jian Jiao; Xintao Cao; Jianhua Wang
Journal:  BMC Microbiol       Date:  2015-03-03       Impact factor: 3.605

4.  Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus.

Authors:  Huixian Chen; Ruoyu Mao; Da Teng; Xiumin Wang; Ya Hao; Xingjun Feng; Jianhua Wang
Journal:  AMB Express       Date:  2017-02-22       Impact factor: 3.298

5.  Production of a modified peptide clavanin in Pichia pastoris: cloning, expression, purification and in vitro activities.

Authors:  Kelly Cristina Mulder; Loiane Alves de Lima; Priscilla Santos Aguiar; Fábio Correa Carneiro; Octávio Luiz Franco; Simoni Campos Dias; Nádia Skorupa Parachin
Journal:  AMB Express       Date:  2015-08-06       Impact factor: 3.298

6.  Determination of multidrug resistance mechanisms in Clostridium perfringens type A isolates using RNA sequencing and 2D-electrophoresis.

Authors:  Yu-Hua Ma; Gui-Sheng Ye
Journal:  Braz J Med Biol Res       Date:  2018-06-11       Impact factor: 2.590

Review 7.  Carrier proteins for fusion expression of antimicrobial peptides in Escherichia coli.

Authors:  Yifeng Li
Journal:  Biotechnol Appl Biochem       Date:  2009-07-06       Impact factor: 2.431

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.